Supriya Lifescience: Judicial Proceedings Status Unchanged

Supriya Lifescience Ltd has provided an update on the judicial proceedings involving its General Manager – Sales & Marketing. The company reiterates that the matter remains sub judice and is awaiting adjudication. This status was previously communicated to investors through earnings calls and transcripts in August 2026. As of the current date, there have been no new developments or orders from the court. The company will continue to monitor the situation and will inform the stock exchanges of any material changes.